Pfizer

Latest clinical program signals indexed for Pfizer.

1. Zavicefta, Ceftazidime-Avibactam — Approved

   Jun 8, 2026
   Clinical update →

2. Zavegepant — Phase 3

   Jun 8, 2026
   Clinical update →

3. valdecoxib — Approved

   Jun 8, 2026
   Clinical update →

4. Tofacitinib with methotrexate — Approved

   Jun 8, 2026
   Clinical update →

5. temsirolimus — Approved

   Jun 8, 2026
   Clinical update →

6. talazoparib plus enzalutamide — Phase 3

   Jun 8, 2026
   Clinical update →

7. Sunitinib, Pemetrexed — Phase 1

   Jun 8, 2026
   Clinical update →

8. sunitinib malate — Phase 3

   Jun 8, 2026
   Clinical update →

1. NCT00038467

   Tamoxifen

   Phase 3 · completed · small_molecule

   Breast Neoplasms

   CT.gov ↗
2. NCT00068952

   Edotecarin

   Phase 3 · completed · small_molecule

   Glioblastoma

   CT.gov ↗
3. NCT00139698

   olmesartan alone or in combination with hydrochlorothiazide

   Phase 3 · completed · small_molecule

   Essential Hypertension

   CT.gov ↗
4. NCT00143234

   Amlodipine/atorvastatin single pill

   Phase 3 · completed · small_molecule

   Hypertension

   CT.gov ↗
5. NCT00147589

   Eplerenone

   Phase 3 · completed · small_molecule

   Hypertension

   CT.gov ↗
6. NCT00147615

   Eplerenone

   Phase 3 · completed · small_molecule

   Hypertension

   CT.gov ↗
7. NCT00150202

   pegaptanib sodium

   Phase 3 · completed · small_molecule

   Macular Degeneration

   CT.gov ↗
8. NCT00156078

   pregabalin

   Approved · completed · small_molecule

   Diabetic Neuropathy, Painful

   CT.gov ↗
9. NCT00232180

   Eplerenone

   Phase 3 · completed · small_molecule

   Heart Failure

   CT.gov ↗
10. NCT00254566

    Moxifloxacin

    Phase 3 · completed · small_molecule

    Chronic Bronchitis

    CT.gov ↗
11. NCT00257192

    placebo

    Phase 3 · terminated · small_molecule

    Schizophrenia

    CT.gov ↗
12. NCT00373113

    Capecitabine

    Phase 3 · terminated · small_molecule

    Breast Neoplasms

    CT.gov ↗
13. NCT00381095

    Pregabalin

    Approved · terminated · small_molecule

    Bone Neoplasms

    CT.gov ↗
14. NCT00389441

    AG-013736

    Phase 2 · completed · small_molecule

    Thyroid Neoplasms

    CT.gov ↗
15. NCT00407537

    Amlodipine besylate/atorvastatin calcium single pill combination

    Approved · completed · small_molecule

    Hypertension

    CT.gov ↗
16. NCT00413699

    CP-690,550

    Phase 3 · completed · small_molecule

    Arthritis, Rheumatoid

    CT.gov ↗
17. NCT00427934

    Maraviroc

    Phase 2 · terminated · small_molecule

    Arthritis, Rheumatoid

    CT.gov ↗
18. NCT00430716

    Sildenafil citrate

    Approved · terminated · small_molecule

    Pulmonary Arterial Hypertension

    CT.gov ↗
19. NCT00483548

    Ziprasidone

    Phase 3 · completed · small_molecule

    Bipolar Disorder

    CT.gov ↗
20. NCT00537238

    pregabalin

    Phase 3 · completed · small_molecule

    Partial Seizures

    CT.gov ↗
21. NCT00537329

    Anidulafungin

    Phase 3 · completed · small_molecule

    Candidemia

    CT.gov ↗
22. NCT00542009

    CE-326,597 100 mg QD

    Phase 2 · completed · small_molecule

    Weight Management

    CT.gov ↗
23. NCT00562965

    inotuzumab ozogamicin

    Phase 3 · terminated · small_molecule

    Lymphoma, Follicular

    CT.gov ↗
24. NCT00574873

    Bosutinib

    Phase 3 · completed · small_molecule

    Chronic Myeloid Leukemia

    CT.gov ↗
25. NCT00603473

    gabapentin

    Phase 3 · completed · small_molecule

    Epilepsies, Partial

    CT.gov ↗
26. NCT00631371

    Bevacizumab

    Phase 3 · completed · small_molecule

    Renal Cell Carcinoma

    CT.gov ↗
27. NCT00643734

    azithromycin sustained release

    Phase 3 · completed · small_molecule

    Pneumonia

    CT.gov ↗
28. NCT00644449

    azithromycin SR (Zithromax; compound: CP-62,993)

    Phase 3 · completed · small_molecule

    Bronchitis, Chronic

    CT.gov ↗
29. NCT00644605

    sildenafil

    Phase 3 · completed · small_molecule

    Hypertension, Pulmonary

    CT.gov ↗
30. NCT00647543

    Atorvastatin

    Approved · completed · small_molecule

    Dyslipidemias

    CT.gov ↗
31. NCT00650598

    valdecoxib

    Approved · completed · small_molecule

    Pain, Postoperative

    CT.gov ↗
32. NCT00667810

    bapineuzumab

    Phase 3 · terminated · small_molecule

    Alzheimer Disease

    CT.gov ↗
33. NCT00673049

    CP 751,871 (Figitumumab)

    Phase 3 · terminated · small_molecule

    Carcinoma, Large Cell

    CT.gov ↗
34. NCT00699374

    sunitinib malate

    Phase 3 · terminated · small_molecule

    Carcinoma, Hepatocellular

    CT.gov ↗
35. NCT00716859

    Timolol

    Phase 3 · completed · small_molecule

    Glaucoma

    CT.gov ↗
36. NCT00721409

    PD 0332991

    Phase 2 · completed · small_molecule

    Breast Cancer

    CT.gov ↗
37. NCT00732992

    Sunitinib, Pemetrexed

    Phase 1 · completed · small_molecule

    Neoplasm, Malignant

    CT.gov ↗
38. NCT00795639

    Sitaxsentan

    Phase 3 · terminated · small_molecule

    Pulmonary Arterial Hypertension

    CT.gov ↗
39. NCT00807846

    Celecoxib

    Approved · completed · small_molecule

    Arthritis, Juvenile Rheumatoid

    CT.gov ↗
40. NCT00814307

    CP-690,550

    Phase 3 · completed · small_molecule

    Arthritis, Rheumatoid

    CT.gov ↗
41. NCT00823979

    UK-453,061 Dose 1

    Phase 2 · terminated · small_molecule

    HIV-1

    CT.gov ↗
42. NCT00894374

    Artesunate (Test)

    Phase 1 · completed · small_molecule

    Falciparum Malaria

    CT.gov ↗
43. NCT00932451

    PF-02341066

    Phase 3 · completed · small_molecule

    Carcinoma, Non-Small-Cell Lung

    CT.gov ↗
44. NCT00932893

    PF-02341066

    Phase 3 · completed · small_molecule

    Carcinoma, Non-Small-Cell Lung

    CT.gov ↗
45. NCT00936065

    Etanercept

    Approved · completed · small_molecule

    Moderate to Severe Psoriasis

    CT.gov ↗
46. NCT00977015

    Treatment A

    Phase 1 · completed · small_molecule

    Healthy

    CT.gov ↗
47. NCT01039688

    CP-690,550

    Phase 3 · completed · small_molecule

    Arthritis, Rheumatoid

    CT.gov ↗
48. NCT01043276

    Treatment A

    Phase 1 · completed · small_molecule

    Asthma

    CT.gov ↗
49. NCT01049217

    pregabalin

    Phase 3 · terminated · small_molecule

    Neuropathy

    CT.gov ↗
50. NCT01122498

    BMP-655/ACS+Standard of care or Standard of care

    Phase 1 · terminated · mab

    Rotator Cuff Tear

    CT.gov ↗
51. NCT01143805

    Tasocitinib 10 mg oral tablet

    Phase 1 · completed · small_molecule

    Healthy

    CT.gov ↗
52. NCT01180049

    temsirolimus

    Approved · completed · small_molecule

    Non-Hodgkin's Lymphoma

    CT.gov ↗
53. NCT01186757

    PF-03715455

    Phase 1 · completed · small_molecule

    Healthy Volunteers

    CT.gov ↗
54. NCT01262677

    pregabalin

    Phase 3 · completed · small_molecule

    Partial Seizures

    CT.gov ↗
55. NCT01287897

    PF-04236921 SC injection

    Phase 2 · completed · small_molecule

    Crohn's Disease

    CT.gov ↗
56. NCT01321463

    PH-797804

    Phase 2 · completed · small_molecule

    Pulmonary Disease, Chronic Obstructive

    CT.gov ↗
57. NCT01337765

    BEZ235 + MEK162

    Phase 1 · completed · small_molecule

    Unspecified Adult Solid Tumor, Protocol Specific

    CT.gov ↗
58. NCT01371838

    Ceftaroline

    Phase 3 · completed · small_molecule

    Community-Acquired Bacterial Pneumonia

    CT.gov ↗
59. NCT01458574

    Placebo

    Phase 3 · completed · small_molecule

    Ulcerative Colitis

    CT.gov ↗
60. NCT01499290

    CAZ-AVI

    Phase 3 · completed · small_molecule

    Complicated Intra-Abdominal Infection

    CT.gov ↗
61. NCT01513928

    Pf-04937319

    Phase 1 · completed · small_molecule

    Healthy

    CT.gov ↗
62. NCT01522807

    PF-05190457

    Phase 1 · completed · small_molecule

    Diabetes Mellitus, Type 2

    CT.gov ↗
63. NCT01599377

    tofacitinib 10 mg

    Phase 1 · completed · small_molecule

    Healthy

    CT.gov ↗
64. NCT01644643

    Ceftazidime - Avibactam ( CAZ-AVI)

    Phase 3 · completed · small_molecule

    Complicated Urinary Tract Infection

    CT.gov ↗
65. NCT01726023

    Ceftazidime-avibactam

    Phase 3 · completed · small_molecule

    Complicated Intra-abdominal Infection

    CT.gov ↗
66. NCT01740427

    PD-0332991

    Phase 3 · completed · small_molecule

    Breast Neoplasms

    CT.gov ↗
67. NCT01838044

    pregabalin and celecoxib

    Approved · terminated · small_molecule

    Chronic Low Back Pain With a Neuropathic Component

    CT.gov ↗
68. NCT01877668

    Tofacitinib 5 mg BID

    Phase 3 · completed · small_molecule

    Psoriatic Arthritis

    CT.gov ↗
69. NCT01911273

    PF-03446962

    Phase 2 · terminated · small_molecule

    Carcinoma, Hepatocellular

    CT.gov ↗
70. NCT01942135

    Palbociclib

    Phase 3 · completed · small_molecule

    Metastatic Breast Cancer

    CT.gov ↗
71. NCT01975389

    bococizumab (PF-04950615)

    Phase 3 · terminated · small_molecule

    Cardiovascular Disease

    CT.gov ↗
72. NCT01989676

    PF-05280014

    Phase 3 · completed · mab

    Metastatic Breast Cancer

    CT.gov ↗
73. NCT02072824

    Pregabalin Dose Level 1

    Phase 3 · completed · small_molecule

    Partial Onset Seizures

    CT.gov ↗
74. NCT02100228

    Apixaban

    Approved · completed · small_molecule

    Atrial Fibrillation

    CT.gov ↗
75. NCT02187055

    Tofacitinib with methotrexate

    Approved · completed · small_molecule

    Rhematoid Arthritis

    CT.gov ↗
76. NCT02213263

    PF-05280586

    Phase 3 · completed · mab

    Follicular Lymphoma

    CT.gov ↗
77. NCT02222493

    PF-06438179

    Phase 3 · completed · mab

    Rheumatoid Arthritis

    CT.gov ↗
78. NCT02364999

    Bevacizumab-Pfizer

    Phase 3 · completed · small_molecule

    Non-Small Cell Lung Cancer

    CT.gov ↗
79. NCT02996500

    PF-06650833

    Phase 2 · completed · small_molecule

    Rheumatoid Arthritis

    CT.gov ↗
80. NCT03189745

    MenACWY-TT

    Phase 3 · completed · mab

    Meningococcal ACWY Disease

    CT.gov ↗
81. NCT03329092

    ATM-AVI

    Phase 3 · completed · small_molecule

    Complicated Intra-abdominal Infection

    CT.gov ↗
82. NCT03580044

    ATM-AVI

    Phase 3 · terminated · other

    Serious Bacterial Infection

    CT.gov ↗
83. NCT03642132

    Chemotherapy + avelumab followed by avelumab + talazoparib

    Phase 3 · terminated · small_molecule

    Ovarian Cancer

    CT.gov ↗
84. NCT03677596

    inotuzumab ozogamicin-dose level 2

    Approved · completed · small_molecule

    Leukemia

    CT.gov ↗
85. NCT03732807

    PF-06651600 Induction Dose

    Phase 3 · completed · small_molecule

    Alopecia Areata

    CT.gov ↗
86. NCT04165317

    PF-06801591

    Phase 3 · active · small_molecule

    Non-muscle Invasive Bladder Cancer

    CT.gov ↗
87. NCT04237792

    dexmedetomidine

    Approved · completed · small_molecule

    MRI Sedation

    CT.gov ↗
88. NCT04404283

    Brentuximab vedotin

    Phase 3 · active · small_molecule

    Diffuse Large B-cell Lymphoma

    CT.gov ↗
89. NCT04424316

    RSVpreF

    Phase 3 · completed · mab

    Respiratory Tract Infection

    CT.gov ↗
90. NCT04585815

    Sasanlimab Prefilled syringe

    Phase 2 · terminated · small_molecule

    Carcinoma, Non-Small-Cell Lung

    CT.gov ↗
91. NCT04774094

    Zavicefta, Ceftazidime-Avibactam

    Approved · completed · small_molecule

    Hospital-Acquired Pneumonia

    CT.gov ↗
92. NCT04821622

    talazoparib plus enzalutamide

    Phase 3 · active · small_molecule

    Prostate Cancer

    CT.gov ↗
93. NCT04863417

    PF-07038124 or vehicle

    Phase 1 · completed · small_molecule

    Healthy

    CT.gov ↗
94. NCT04879329

    disitamab vedotin

    Phase 2 · active · small_molecule

    Urothelial Carcinoma

    CT.gov ↗
95. NCT04960202

    PF-07321332

    Phase 3 · completed · small_molecule

    COVID-19

    CT.gov ↗
96. NCT05011513

    PF-07321332

    Phase 3 · completed · small_molecule

    COVID-19

    CT.gov ↗
97. NCT05059522

    Avelumab

    Phase 3 · active · small_molecule

    Advanced Malignancies

    CT.gov ↗
98. NCT05070845

    PF-06835375

    Phase 2 · active · mab

    Primary Immune Thrombocytopenia

    CT.gov ↗
99. NCT05156398

    Rimegepant

    Phase 3 · active · small_molecule

    Migraine

    CT.gov ↗
100. NCT05540522

     Quadrivalent influenza modRNA vaccine

     Phase 3 · completed · mab

     Influenza, Human

     CT.gov ↗
101. NCT05989048

     Zavegepant

     Phase 3 · completed · small_molecule

     Migraine

     CT.gov ↗
102. NCT06102174

     Placebo

     Phase 1 · terminated · small_molecule

     Respiratory Syncytial Virus Infections

     CT.gov ↗
103. NCT06758401

     Sigvotatug Vedotin

     Phase 3 · active · small_molecule

     Non-Small Cell Lung Cancer

     CT.gov ↗
104. NCT07363694

     PF-07275315 dose 1

     Phase 3 · active · small_molecule

     Moderate to Severe Chronic Obstructive Pulmonary Disease

     CT.gov ↗